Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Hosp Palliat Care ; 41(2): 133-139, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37050888

ABSTRACT

BACKGROUND: Currently, palliative care plays an important role in increasingly aging populations and their long-term care needs. Surgical palliative care is important for improving quality of life. This study aimed to determine the knowledge level of nurses working in surgical clinics about palliative surgery. METHOD: This research was conducted as a descriptive study. We included 182 nurses working in surgical clinics who agreed to participate and met the inclusion criteria for participation in the study. The Personal Information and Palliative Surgery Information Forms were used to collect data. Data were collected between November 30, and December 15, 2022. The analysis of the data obtained was performed using the Statistical Program in Social Sciences (SPSS), Version 25. The level of significance was set at P < .05. RESULTS: Nurses referred to palliative care as end-of-life care, 73.1% did not care for palliative care patients, and 84.6% did not receive training in palliative care. Surgical clinic nurses were found to have "moderate knowledge about palliative surgery. A statistically significant difference was found between the average palliative surgery knowledge of surgical clinic nurses and those trained in education and palliative care (P < .05). CONCLUSIONS: The results of the study showed that surgical clinic nurses had moderate knowledge about palliative surgery. Moreover, the nurses who have received training in palliative care and had high level of education exhibited a higher level of knowledge.


Subject(s)
Nurses , Terminal Care , Humans , Palliative Care/methods , Quality of Life , Clinical Competence , Surveys and Questionnaires
2.
J Clin Med ; 12(13)2023 Jul 03.
Article in English | MEDLINE | ID: mdl-37445501

ABSTRACT

BACKGROUND: In liver transplant (LT) recipients, immunosuppressive therapy may potentially increase the risk of severe COVID-19 and may increase the mortality in patients. However, studies have shown conflicting results, with various studies reporting poor outcomes while the others show no difference between the LT recipients and healthy population. The aim of this study is to determine the impact of the COVID-19 pandemic on survival of LT recipients. METHODS: This is a retrospective cohort study analyzing the data from 387 LT recipients diagnosed with COVID-19. LT recipients were divided into two groups: survival (n = 359) and non-survival (n = 28) groups. A logistic regression model was used to determine the independent risk factors for mortality. Machine learning models were used to analyze the contribution of independent variables to the mortality in LT recipients. RESULTS: The COVID-19-related mortality rate in LT recipients was 7.2%. Multivariate analysis showed that everolimus use (p = 0.012; OR = 6.2), need for intubation (p = 0.001; OR = 38.4) and discontinuation of immunosuppressive therapy (p = 0.047; OR = 7.3) were independent risk factors for mortality. Furthermore, COVID-19 vaccination reduced the risk of mortality by 100 fold and was the single independent factor determining the survival of the LT recipients. CONCLUSION: The effect of COVID-19 infection on LT recipients is slightly different from the effect of the disease on the general population. The COVID-19-related mortality is lower than the general population and vaccination for COVID-19 significantly reduces the risk of mortality.

3.
Diagnostics (Basel) ; 13(8)2023 Apr 13.
Article in English | MEDLINE | ID: mdl-37189511

ABSTRACT

BACKGROUND: The primary aim of this study was to compare liver transplant (LT) recipients with and without hepatocellular carcinoma (HCC) in terms of COVID-19-related depression, anxiety, and stress. METHOD: A total of 504 LT recipients with (HCC group; n = 252) and without HCC (non-HCC group; n = 252) were included in the present case-control study. Depression Anxiety Stress Scales (DASS-21) and Coronavirus Anxiety Scale (CAS) were used to evaluate the depression, stress, and anxiety levels of LT patients. DASS-21 total and CAS-SF scores were determined as the primary outcomes of the study. Poisson regression and negative binomial regression models were used to predict the DASS and CAS scores. The incidence rate ratio (IRR) was used as a coefficient. Both groups were also compared in terms of awareness of the COVID-19 vaccine. RESULTS: Poisson regression and negative binomial regression analyses for DASS-21 total and CAS-SF scales showed that the negative binomial regression method was the appropriate model for both scales. According to this model, it was determined that the following independent variables increased the DASS-21 total score: non-HCC (IRR: 1.26; p = 0.031), female gender (IRR: 1.29; p = 0.036), presence of chronic disease (IRR: 1.65; p < 0.001), exposure to COVID-19 (IRR: 1.63; p < 0.001), and nonvaccination (IRR: 1.50; p = 0.002). On the other hand, it was determined that the following independent variables increased the CAS score: female gender (IRR:1.75; p = 0.014) and exposure to COVID-19 (IRR: 1.51; p = 0.048). Significant differences were found between the HCC and non-HCC groups in terms of median DASS-21 total (p < 0.001) and CAS-SF (p = 0.002) scores. Cronbach's alpha internal consistency coefficients of DASS-21 total and CAS-SF scales were calculated to be 0.823 and 0.783, respectively. CONCLUSION: This study showed that the variables including patients without HCC, female gender, having a chronic disease, being exposed to COVID-19, and not being vaccinated against COVID-19 increased anxiety, depression, and stress. High internal consistency coefficients obtained from both scales indicate that these results are reliable.

4.
Transplant Proc ; 55(5): 1226-1230, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37137762

ABSTRACT

BACKGROUND AND AIM: Many clinical studies have shown that the COVID-19 case fatality rate is higher in older patients, those with comorbidities, those with immunosuppressive conditions, and those who stay in the intensive care unit. This study aims to evaluate the clinical outcomes of 66 liver transplant (LT) patients with primary liver cancer who were exposed to COVID-19 infection. METHODS: Demographic and clinical data of 66 patients with primary liver cancer (hepatocellular carcinoma = 64, hepatoblastoma = 1, cholangiocarcinoma = 1) who underwent LT in our institute and were exposed to COVID-19 infection between March 2020 and November 2021 were analyzed in this cross-sectional study. The following data of the patients were recorded: age, sex, body mass index (kg/m2), blood group, underlying primary liver disease, smoking, tumor characteristics, post-transplant immunosuppressive agents, COVID-19 symptoms, hospitalization, intensive care unit stay, intubation, and other clinical features. RESULTS: There were 55 (83.3%) male and 11 (16.7%) female patients, with a median age of 58 years. Sixty-four patients were exposed to COVID-19 only once, whereas the remaining 2 patients were exposed 2 and 4 times, respectively. After exposure to COVID-19, it was determined that 37 patients used antiviral drugs, 25 were hospitalized, 9 were followed in the intensive care unit, and 3 were intubated. One intubated patient was under hospital follow-up because of biliary complications before exposure to COVID-19, and this patient died from sepsis. CONCLUSION: The low mortality rate of LT patients with primary liver cancer exposed to COVID-19 infection can be attributed to background immunosuppression that prevents cytokine storm. However, it is appropriate to support this study with multicenter studies to make strong comments on this issue.


Subject(s)
COVID-19 , Carcinoma, Hepatocellular , Liver Neoplasms , Liver Transplantation , Humans , Male , Female , Aged , Middle Aged , COVID-19/epidemiology , Carcinoma, Hepatocellular/surgery , SARS-CoV-2 , Liver Transplantation/adverse effects , Pandemics , Cross-Sectional Studies , Liver Neoplasms/surgery , Immunosuppressive Agents/adverse effects
5.
Transpl Immunol ; 72: 101564, 2022 06.
Article in English | MEDLINE | ID: mdl-35257894

ABSTRACT

BACKGROUND: This study was descriptive, prospective, and correlational conducted to evaluate the investigate the relationship between pain beliefs and postoperative pain severity in liver transplant patients. METHODS: The study included 118 liver transplant patients. Pain beliefs in the preoperative period were assessed by the Pain Beliefs Scale. Pain intensity was evaluated using the Numerical Rating Scale in postoperative 24-72 h. Multiple normal distribution and homogeneity of variance in the analyses were checked using the SPSS 25 package program, and Structural Equation Modeling was established. Whether the severity of pain and pain beliefs were affected by sociodemographic, disease, and pain characteristics was assessed. RESULTS: It was found that the mean pain severity of the patients was low. Mean psychological belief value was higher than the organic belief value. It was observed that there was a moderate positive correlation between the patients' mean pain severity score and pain belief total and sub-dimension score means (p < 0.05). In the Structural Equation Modeling established, it was found that psychological beliefs were more effective than organic beliefs on pain severity. CONCLUSION: The results of our study show that pain beliefs and pain severity are related. This study suggests a new perspective on the role of clinical and demographic factors on postoperative pain and shows that determining pain beliefs is important in pain control.


Subject(s)
Liver Transplantation , Humans , Pain Measurement , Pain, Postoperative , Prospective Studies , Surveys and Questionnaires
6.
Transpl Immunol ; 69: 101479, 2021 12.
Article in English | MEDLINE | ID: mdl-34626805

ABSTRACT

BACKGROUND: This study was descriptively conducted to evaluate the fear of COVID 19 and its social effects on patients who had liver transplant. METHODS: The study was conducted between September 2020 and April 2021 in a liver transplant institute affiliated with a university hospital. The sample of the study was 135 patients. Personal Information Form, Fear of Covid 19 Scale, and Questionnaire of Social Impact of COVID 19 Pandemic were used to collect data. RESULTS: It was determined that the Fear of Covid 19 Scale mean score of the patients was 21.25 ± 6.99. As the fear of COVID 19 increases in patients who had liver transplant, it was determined that their desire to be in crowded environments, to prefer public transportation, to go to the doctor for examination and their focusing on various objectives were decreasing. Also, fear of COVID 19 increased the difficulty in sleep, storage of food and cleaning materials, washing hands frequently, using masks and gloves when going out, health concerns, doubts about disease symptoms, orientation towards healthy eating, worries about the future and questioning the meaning of life. CONCLUSION: The results show that it is important for transplant centers to be able to provide guidance and psychological counseling services to liver transplant patients, who are significantly affected by COVID 19, through telemedicine or various technological opportunities.


Subject(s)
Activities of Daily Living/psychology , Attitude to Death , COVID-19/psychology , Fear/psychology , Liver Transplantation/psychology , COVID-19/mortality , Cross-Sectional Studies , Female , Humans , Male , SARS-CoV-2 , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...